(Q52192755)

26 April 2018

title

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. (English)

1 reference

26 April 2018

author name string

Cao BJ

series ordinal

1

1 reference

26 April 2018

Rodgers RJ

series ordinal

2

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

58

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

593-603

1 reference

26 April 2018

5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effects of (-)-pindolol and SDZ 216-525 on social and agonistic behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

5-HT1A receptor agonists: recent developments and controversial issues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S 21,357.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Anti-conflict effect of 5-HT1A agonists in rats: a new model for evaluating anxiolytic-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Stimulation of postsynaptic 5-HT1A receptors is responsible for the anticonflict effect of ipsapirone in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

The role of hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Development of 5-HT1A receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Dexmedetomidine synergism with midazolam in the elevated plus-maze test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

The concept of selectivity in 5-HT receptor research

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

Stress-induced hyperthermia as a putative anxiety model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900279-7

7 January 2021

10.1016/S0091-3057(97)00279-7

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018